AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33034872 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall awareness and practice of BSE and screening
Number of subjects: 202
Study 33251832 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac
Number of subjects: 45
Study 33251832 — intervention group
Group type: COMPARATOR
Intervention: Nepafenac-free
Number of subjects: 45
Study 32654629 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive total fatty acid intake
Number of subjects: 60
Study 32654629 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-6/omega-3 ratio above 10:1
Number of subjects: 60
Study 32028138 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 120
Study 32028138 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily
Number of subjects: 120
Study 34047449 — intervention group
Group type: EXPERIMENTAL
Intervention: FiASP-and-pramlintide with SMA
Number of subjects: 7
Study 34047449 — intervention group
Group type: COMPARATOR
Intervention: FiASP-and-placebo with FCC
Number of subjects: 7
Study 34047449 — intervention group
Group type: COMPARATOR
Intervention: FiASP-and-placebo with SMA
Number of subjects: 7
Study 34047449 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 7
Study 34047449 — intervention group
Group type: COMPARATOR
Intervention: FiASP-and-placebo with FCC and SMA interventions
Number of subjects: 7
Study 33252896 — intervention group
Group type: EXPERIMENTAL
Intervention: Resourcefulness Training + Routine Health Education
Number of subjects: 72
Study 33252896 — intervention group
Group type: COMPARATOR
Intervention: Routine Health Education
Number of subjects: 72
Study 34304121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine RCTs
Number of subjects: 1689
Study 34304121 — intervention group
Group type: COMPARATOR
Intervention: Methamphetamine RCTs
Number of subjects: 1689
Study 32479329 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical activity in the previous hour
Number of subjects: 43
Study 32479329 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity in the previous hour
Number of subjects: 43
Study 35654226 — intervention group
Group type: EXPERIMENTAL
Intervention: cEEG (30-48 hours)
Number of subjects: 112
Study 35654226 — intervention group
Group type: COMPARATOR
Intervention: rEEG (two sessions of 20-30 minutes each)
Number of subjects: 112
Study 34174564 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary tryptophan levels of 1.00, 2.00, 3.00, 4.00, 5.00, and 6.00 g/kg
Number of subjects: 504
Study 32869396 — intervention group
Group type: EXPERIMENTAL
Intervention: Brighton Collaboration GBS case definitions applied to retrospective cohort
Number of subjects: 0
Study 32869396 — intervention group
Group type: EXPERIMENTAL
Intervention: Brighton Collaboration GBS case definitions applied to prospective cohort
Number of subjects: 0
Study 32869396 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF investigations conducted in all patients
Number of subjects: 0
Study 32869396 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve conduction studies performed in cohorts
Number of subjects: 0
Study 35670155 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC-CG (Managing Cancer Care: A Caregiver's Guide)
Number of subjects: 35
Study 34303444 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers' self-efficacy beliefs, relationship experiences, and externalizing symptom ratings
Number of subjects: 690
Study 34303444 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers' experience level
Number of subjects: 690
Study 34303444 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's levels of closeness
Number of subjects: 690
Study 34267120 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic Saws
Number of subjects: 258
Study 34267120 — intervention group
Group type: COMPARATOR
Intervention: Conventional Osteotomes
Number of subjects: 258
Study 33676589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 6 mg/kg plus standard care
Number of subjects: 180
Study 33676589 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 180
Study 32180507 — intervention group
Group type: EXPERIMENTAL
Intervention: Kripalu Yoga in the Schools (KYIS) intervention integrated into physical education class (n = 9)
Number of subjects: 23
Study 32180507 — intervention group
Group type: COMPARATOR
Intervention: Art and music (control condition; n = 14)
Number of subjects: 23
Study 33564844 — intervention group
Group type: COMPARATOR
Intervention: Heavy resistance training 3 times weekly with whey protein supplementation (HRTW)
Number of subjects: 208
Study 33564844 — intervention group
Group type: COMPARATOR
Intervention: Light-intensity resistance training 3-5 times/wk with whey protein supplementation (LITW)
Number of subjects: 208
Study 33564844 — intervention group
Group type: COMPARATOR
Intervention: Collagen protein supplementation (COLL)
Number of subjects: 208
Study 33564844 — intervention group
Group type: COMPARATOR
Intervention: Whey protein supplementation (WHEY)
Number of subjects: 208
Study 32401967 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic acrylic square‐edged IOLs
Number of subjects: 26
Study 32401967 — intervention group
Group type: COMPARATOR
Intervention: Hydrophilic acrylic square‐edged IOLs
Number of subjects: 26
Study 32401967 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study 35762773 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-free exercise (PF)
Number of subjects: 51
Study 35762773 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate pain exercise (MOD-P)
Number of subjects: 51
Study 35762773 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal pain exercise (MAX-P)
Number of subjects: 51
Study 33395498 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly Structured Interdisciplinary Bedside Rounds (SIBR)
Number of subjects: 3673
Study 32036824 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC dressing after split thickness skin graft
Number of subjects: 120
Study 32036824 — intervention group
Group type: COMPARATOR
Intervention: Simple dressing after split thickness skin graft
Number of subjects: 120
Study 35973183 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acustimulation (TEA)
Number of subjects: 52
Study 35973183 — intervention group
Group type: COMPARATOR
Intervention: Sham-TEA
Number of subjects: 52
Study 34470322 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Porous Coated Cylinders (SPCCs)
Number of subjects: 0
Study 34470322 — intervention group
Group type: COMPARATOR
Intervention: Control (bare cylinder)
Number of subjects: 0
Study 35795897 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week health education program applying social marketing and Health Belief Model (HBM)
Number of subjects: 150
Study 35795897 — intervention group
Group type: COMPARATOR
Intervention: Usual services (comparison group)
Number of subjects: 150
Study 34728206 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 monitors intervention
Number of subjects: 12
Study 34728206 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) control
Number of subjects: 12
Study 34728206 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 12
Study 34728206 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention
Number of subjects: 12
Study 34728206 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 12
Study 32620866 — intervention group
Group type: EXPERIMENTAL
Intervention: Spa-rehab therapy
Number of subjects: 283
Study 32620866 — intervention group
Group type: COMPARATOR
Intervention: Standard spa therapy
Number of subjects: 283
Study 36114653 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester (27 g per dose, thrice daily for 3 days)
Number of subjects: 16
Study 36114653 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric maltodextrin placebo (PLA)
Number of subjects: 16
Study 36114653 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester (KES)
Number of subjects: 16
Study 36114653 — intervention group
Group type: COMPARATOR
Intervention: Both KES and PLA
Number of subjects: 16
Study 34390228 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 60
Study 34390228 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study 35330843 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacus mental calculation training (AMC); specific dosage and duration not mentioned.
Number of subjects: 28
Study 35775225 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (circuit-based aerobic and resistance exercise, 65-85% of VO2max and 65-85% of 1-repetition maximum, 3 times per week for 16 weeks)
Number of subjects: 90
Study 35775225 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study 35775225 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 90
Study 33831271 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox (n=35)
Number of subjects: 71
Study 33831271 — intervention group
Group type: COMPARATOR
Intervention: Air-oxygen mixed gas (Control group, n=36)
Number of subjects: 71
Study 32410379 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration using autogenous bone/deproteinized bovine bone mineral grafting mixture and collagen membrane
Number of subjects: 15
Study 32410379 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration
Number of subjects: 15
Study 36513442 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate daily consumption of cachaça (28 g ethanol/day for men, 14 g for women)
Number of subjects: 40
Study 36513442 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate daily consumption of red wine (28 g ethanol/day for men, 14 g for women)
Number of subjects: 40
Study 33797681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention (OR=1.49, 95% CI=1.21-1.84, p=0.001)
Number of subjects: 633
Study 33797681 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective norm (OR=1.57, 95% CI=1.15-2.13, p=0.004)
Number of subjects: 633
Study 33797681 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived behavioural control (OR=1.53, 95% CI=1.21-1.92, p=0.001)
Number of subjects: 633
Study 33797681 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived severity (OR=1.57, 95% CI=1.15-2.16, p=0.005)
Number of subjects: 633
Study 33797681 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived barriers (OR=0.52, 95% CI=0.39-0.67, p=0.001)
Number of subjects: 633
Study 32224129 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control strategy (increased therapy based on fecal calprotectin, serum C-reactive protein, and symptoms)
Number of subjects: 122
Study 32224129 — intervention group
Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 122
Study 32224129 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep remission (CD endoscopic index of severity scores below 4, no deep ulcerations or steroid treatment for 8 or more weeks)
Number of subjects: 122
Study 33969511 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication reconciliation model led by a hospital clinical pharmacist
Number of subjects: 353
Study 32554766 — intervention group
Group type: EXPERIMENTAL
Intervention: Goals-of-care decision aid
Number of subjects: 18
Study 34964311 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day plus rifaximin 1,200 mg/day for 3 months
Number of subjects: 42
Study 34964311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 36057024 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT intervention (After Deployment Adaptive Parenting Tools)
Number of subjects: 185
Study 36057024 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 185
Study 34398242 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy (CPT)
Number of subjects: 0
Study 34398242 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32366866 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute slow breathing exercise
Number of subjects: 20
Study 32366866 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening (Max Richter: Sleep)
Number of subjects: 20
Study 32366866 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 20
Study 35451230 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemizole (1 mM, bath application)
Number of subjects: 0
Study 35451230 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (1 mM, bath application)
Number of subjects: 0
Study 35451230 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 0
Study 35451230 — intervention group
Group type: COMPARATOR
Intervention: Valproate (VPA)
Number of subjects: 0
Study 35451230 — intervention group
Group type: COMPARATOR
Intervention: Ethosuximide (ESX)
Number of subjects: 0
Study 35451230 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam (LEV)
Number of subjects: 0
Study 35451230 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (DZP)
Number of subjects: 0
Study 34146594 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-g Alkyrol® (purified shark liver oil) per day for 3 weeks
Number of subjects: 10
Study 34146594 — intervention group
Group type: COMPARATOR
Intervention: Placebo (methylcellulose)
Number of subjects: 10
Study 34388256 — intervention group
Group type: EXPERIMENTAL
Intervention: Overexpansion group (n = 11)
Number of subjects: 23
Study 34388256 — intervention group
Group type: COMPARATOR
Intervention: Conventional expansion group (n = 12)
Number of subjects: 23
Study 33186715 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation (32 hours)
Number of subjects: 46
Study 33186715 — intervention group
Group type: COMPARATOR
Intervention: Normal sleep-wake cycle (SWC)
Number of subjects: 46
Study 32919170 — intervention group
Group type: EXPERIMENTAL
Intervention: Moulage simulation
Number of subjects: 73
Study 32919170 — intervention group
Group type: COMPARATOR
Intervention: Pressure ulcer visuals simulation (Control)
Number of subjects: 73
Study 35940529 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 50 mg/kg daily from 9 days before HSCT to 30 days after HSCT
Number of subjects: 160
Study 33832645 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclon Idra vaginal gel
Number of subjects: 60
Study 33832645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35272801 — intervention group
Group type: EXPERIMENTAL
Intervention: iFR
Number of subjects: 2037
Study 35272801 — intervention group
Group type: COMPARATOR
Intervention: FFR
Number of subjects: 2037
Study 32498639 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with learning difficulties (LD)
Number of subjects: 50
Study 32498639 — intervention group
Group type: COMPARATOR
Intervention: Children without learning difficulties (LD)
Number of subjects: 50
Study 32498639 — intervention group
Group type: EXPERIMENTAL
Intervention: FPlinR, DDR, and ANMF scores
Number of subjects: 50
Study 35190840 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 2410
Study 35190840 — intervention group
Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 2410
Study 35190840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine use
Number of subjects: 2410
Study 35190840 — intervention group
Group type: EXPERIMENTAL
Intervention: SAPS II score ≥ 62
Number of subjects: 2410
Study 35190840 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin concentration ≤ 10.9 g/dL
Number of subjects: 2410
Study 33635894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical transcutaneous vagal nerve stimulation for two weeks
Number of subjects: 0
Study 33635894 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment for two weeks
Number of subjects: 0
Study 33635894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical transcutaneous vagal nerve stimulation
Number of subjects: 0
Study 33635894 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 32734919 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT); 9 sessions, 2 hours each, once weekly (n = 35)
Number of subjects: 63
Study 32734919 — intervention group
Group type: COMPARATOR
Intervention: Computerized Cognitive Training (CCT); 9 sessions, 1 hour each, twice weekly (n = 28)
Number of subjects: 63
Study 34764044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab-hydroxychloroquine (TCZ-HCQ)
Number of subjects: 108
Study 34764044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab-remdesivir (TCZ-RMV)
Number of subjects: 108
Study 33798217 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured cardiac ultrasound education and rotation program
Number of subjects: 23
Study 33433153 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (high-intensity interval training on a cycloergometer thrice a week for 4 months per year)
Number of subjects: 51
Study 33433153 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 51
Study 33433153 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study 32745244 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion adjusted by a standard algorithm
Number of subjects: 94
Study 35266971 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammatory markers (cytokines in tears and HLA-DR expression)
Number of subjects: 535
Study 33290442 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw exercises
Number of subjects: 97
Study 33290442 — intervention group
Group type: COMPARATOR
Intervention: Stabilization appliance
Number of subjects: 97
Study 33290442 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 97
Study 35851976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) intervention
Number of subjects: 192
Study 35851976 — intervention group
Group type: COMPARATOR
Intervention: Health promotion condition
Number of subjects: 192
Study 33938946 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention (standardized online learning for teachers with minimal in-person support, duration 9-10 months)
Number of subjects: 1188
Study 33938946 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (not specified)
Number of subjects: 1188
Study 33938946 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention
Number of subjects: 1188
Study 32014046 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives in addition to interactive management of mobile devices, conditional on achieving antihypertensive goals.
Number of subjects: 400
Study 32014046 — intervention group
Group type: COMPARATOR
Intervention: Interactive management of mobile devices, including patient education and communication.
Number of subjects: 400
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory situation with external incentive
Number of subjects: 0
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory situation without external incentive
Number of subjects: 0
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Online situation with external incentive
Number of subjects: 0
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Online situation without external incentive
Number of subjects: 0
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Public goods game with punishment
Number of subjects: 0
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Public goods game without punishment
Number of subjects: 0
Study 35442983 — intervention group
Group type: EXPERIMENTAL
Intervention: Online-worker sample in public goods game
Number of subjects: 0
Study 33012126 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hearing loss
Number of subjects: 389
Study 33012126 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative history of atopy
Number of subjects: 389
Study 33012126 — intervention group
Group type: EXPERIMENTAL
Intervention: Never using hearing aids
Number of subjects: 389
Study 33012126 — intervention group
Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 389
Study 33012126 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom duration
Number of subjects: 389
Study 34431478 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program and disease management smartphone app
Number of subjects: 107
Study 34431478 — intervention group
Group type: COMPARATOR
Intervention: Control group (only attended visits)
Number of subjects: 107
Study 33219133 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol box
Number of subjects: 36
Study 33219133 — intervention group
Group type: COMPARATOR
Intervention: No aerosol box
Number of subjects: 36
Study 34784996 — intervention group
Group type: EXPERIMENTAL
Intervention: Group electronic hand hygiene monitoring systems (GEHHMS)
Number of subjects: 2812
Study 34784996 — intervention group
Group type: COMPARATOR
Intervention: Baseline hand hygiene adherence without GEHHMS
Number of subjects: 2812
Study 34784996 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous feedback to units using GEHHMS
Number of subjects: 2812
Study 34193162 — intervention group
Group type: EXPERIMENTAL
Intervention: Social and behavioural change (SBC) interventions including community volunteers, worship places, and community dialogue sessions.
Number of subjects: 773
Study 35967104 — intervention group
Group type: EXPERIMENTAL
Intervention: Atacicept 25 mg
Number of subjects: 16
Study 35967104 — intervention group
Group type: EXPERIMENTAL
Intervention: Atacicept 75 mg
Number of subjects: 16
Study 35967104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 33786484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold compress applied to the abdomen before IUD insertion
Number of subjects: 142
Study 33786484 — intervention group
Group type: COMPARATOR
Intervention: Usual management (control group)
Number of subjects: 142
Study 34505206 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle-focused text message intervention
Number of subjects: 160
Study 34505206 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus groups (n=16)
Number of subjects: 160
Study 34505206 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 160
Study 34615593 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 156